Insertion (21;8)(q22;q22q22): A masked t(8;21) in a patient with acute myelocytic leukemia

Cancer Genetics and Cytogenetics

Volumn 147, Issue 2, 2003, Pages 134-139

  Onozawa, Masahiro ^a   Fukuhara, Takashi ^a   Nigo, Motohiko ^a   Takeda, Akinori ^a   Takahata, Mutsumi ^a   Yamamoto, Yasushi ^a   Miyake, Takayoshi ^a   Kanda, Makoto ^a   Maekawa, Isao ^a  

^a Asahikawa City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; MERCAPTOPURINE; PREDNISOLONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AML1 GENE; ARTICLE; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CASE REPORT; CELL MATURATION; CHIMERA; CHROMOSOME 21; CHROMOSOME 8; CHROMOSOME INSERTION; CLINICAL FEATURE; CYTOGENETICS; ETO GENE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XY; LABORATORY DIAGNOSIS; MALE; MOLECULAR PROBE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

INSERTION SEQUENCES;

EID: 0242659256     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00199-7     Document Type: Article

References (16)

1. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) Cooperative Group. Br J Haematol. 33:1976;451-458.
2. Bennett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A., Gralnick H.R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 103:1985;620-625.
3. The Fourth International Workshop on Chromosomes in Leukemia: a prospective study of acute nonlymphocytic leukemia. Chicago, Illinois, USA, September 2-7, 1982. Cancer Genet Cytogenet. 11:1984;249-360.
4. Groupe Français de Cytogénétique Hématologique. Acute myelogenous leukemia with an 8;21 translocation: a report on 148 cases. Cancer Genet Cytogenet. 44:1990;169-179.
5. Maseki N., Miyoshi H., Shimizu K., Homma C., Ohki M., Sakurai M., Kaneko Y. The 8;21 chromosome translocation in acute myeloid leukemia is always detectable by molecular analysis using AML1. Blood. 81:1993;1573-1579.
6. Maruyama F., Yang P., Stass S.A., Cork A., Freireich E.J., Lee M.S., Chang K.S. Detection of the AML1/ETO fusion transcript in the t(8;21) masked translocation in acute myelogeneous leukemia. Cancer Res. 53:1993;4449-4451.
7. Maruyama F., Stass S.A., Estey E.H., Cork A., Hirano M., Ino T., Freireich E.J., Yang P., Chang K.S. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogeneous leukemia. Leukemia. 8:1994;40-45.
8. Oka T., Suzuki Y., Shimizu S., Sakata Y., Azuma H., Kaneko Y. AML1 gene rearrangements, but no 8;21 translocation in a child with acute myeloblastic leukemia (M2). Jpn J Clin Hematol. 35:1994;69-74.
9. Andrieu V., Radford-Weiss I., Troussard X., Chane C., Valensi F., Guesnu M., Haddad E., Viguier F., Dreyfus F., Varet B., Flandrin G., Macintyre E. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol. 92:1996;855-865.
10. Langabeer S.E., Walker H., Rogers J.R., Burnett A.K., Wheatley K., Swirsky D., Goldstone A.H., Linch D.C. Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. Br J Haematol. 99:1997;925-928.
11. Saitoh K., Miura I., Ohshima A., Takahashi N., Kume M., Utsumi S., Kobayashi Y., Hashimoto K., Hatano Y., Nimura T., Saito M., Enomoto K., Ohhira M., Shimizu K., Ohki M., Miura A.B. Translocation (8;12;21)(q22.1;q24.1;q22.1): a new masked type of t(8;21)(q22;q22) in a patient with acute myeloid leukemia. Cancer Genet Cytogenet. 96:1997;111-114.
12. Wong K.F., Kwong Y.L., So C.C. Translocation (8;20;21)(q22;q13;q22) in acute myeloblastic leukemia with maturation: a variant form of t(8;21). Cancer Genet Cytogenet. 101:1998;39-41.
13. Harrison C.J., Radford-Weiss I., Ross F., Rack K., le Guyader G., Vekemans M., Macintyre E. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations. Cancer Genet Cytogenet. 112:1999;15-20.
14. Sarriera J.E., Albitar M., Estrov Z., Gidel C., Aboul-Nasr R., Manshouri T., Kornblau S., Chang K.S., Kantarjian H. Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing. Leukemia. 15:2001;57-61.
15. Miyagi J., Kakazu N., Masuda M., Miyagi T., Toyohama T., Nakazato T., Tomoyose T., Shinjyo T., Nagasaki A., Taira N., Ohki M., Abe T., Takasu N. Acute myeloid leukemia (FAB-M2) with a masked type of t(8;21) translocation revealed by spectral karyotyping. Int J Hematol. 76:2002;338-343.
16. Gamerdinger U., Teigler-Schlegel A., Pils S., Bruch J., Viehmann S., Keller M., Jauch A., Harbott J. Cryptic chromosomal aberrations leading to an AML1/ETO rearrangement are frequently caused by small insertions. Genes Chromosomes Cancer. 36:2003;261-272.